Search research articles
Contact Us
Filters
Showing results (321-330 of 375) with videos related to
Page
of 38
Sort By:
Alzheimer'S & Dementia (New York, N. Y.)
|
August 4, 2023
Effects of methylphenidate on neuropsychiatric symptoms in Alzheimer's disease: Evidence from the ADMET 2 study
Emily D Clark, Jamie Perin, Nathan Herrmann, et al.
International Psychogeriatrics
|
September 19, 2024
Measuring clinically relevant change in apathy symptoms in ADMET and ADMET 2
Shankar Tumati, Nathan Herrmann, Jaime Perin, et al.
International Psychogeriatrics
|
January 31, 2025
Measuring clinically relevant change in apathy symptoms in ADMET and ADMET 2
Shankar Tumati, Nathan Herrmann, Jaime Perin, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry
|
May 29, 2020
Neurobiologic Rationale for Treatment of Apathy in Alzheimer's Disease With Methylphenidate
Christopher H van Dyck, Amy F T Arnsten, Prasad R Padala, et al.
JAMA Neurology
|
September 27, 2021
Effect of Methylphenidate on Apathy in Patients With Alzheimer Disease: The ADMET 2 Randomized Clinical Trial
Jacobo Mintzer, Krista L Lanctôt, Roberta W Scherer, et al.
International Journal of Geriatric Psychiatry
|
June 10, 2024
Adverse effects of methylphenidate for apathy in patients with Alzheimer's disease (ADMET2 trial)
Lijuan Zeng, Jamie Perin, Alden L Gross, et al.
Pacing and Clinical Electrophysiology : PACE
|
October 15, 2010
Implantation success and infection in cardiovascular implantable electronic device procedures utilizing an antibacterial envelope
Heather L Bloom, Luis Constantin, Daniel Dan, et al.
American Journal of Human Genetics
|
January 16, 2002
Mutations in a novel CLN6-encoded transmembrane protein cause variant neuronal ceroid lipofuscinosis in man and mouse
Hanlin Gao, Rose-Mary N Boustany, Janice A Espinola, et al.
Neurology
|
July 12, 2015
Improving clinical cognitive testing: report of the AAN Behavioral Neurology Section Workgroup
Kirk R Daffner, Seth A Gale, A M Barrett, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry
|
June 23, 2020
Measuring Apathy in Alzheimer's Disease in the Apathy in Dementia Methylphenidate Trial 2 (ADMET 2): A Comparison of Instruments
Krista L Lanctôt, Roberta W Scherer, Abby Li, et al.
Page
of 38
Search research articles
Search
Showing results (321-330 of 375) with videos related to
Sort By:
Page
of 38
Alzheimer'S & Dementia (New York, N. Y.)
|
August 4, 2023
Effects of methylphenidate on neuropsychiatric symptoms in Alzheimer's disease: Evidence from the ADMET 2 study
Emily D Clark, Jamie Perin, Nathan Herrmann, et al.
International Psychogeriatrics
|
September 19, 2024
Measuring clinically relevant change in apathy symptoms in ADMET and ADMET 2
Shankar Tumati, Nathan Herrmann, Jaime Perin, et al.
International Psychogeriatrics
|
January 31, 2025
Measuring clinically relevant change in apathy symptoms in ADMET and ADMET 2
Shankar Tumati, Nathan Herrmann, Jaime Perin, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry
|
May 29, 2020
Neurobiologic Rationale for Treatment of Apathy in Alzheimer's Disease With Methylphenidate
Christopher H van Dyck, Amy F T Arnsten, Prasad R Padala, et al.
JAMA Neurology
|
September 27, 2021
Effect of Methylphenidate on Apathy in Patients With Alzheimer Disease: The ADMET 2 Randomized Clinical Trial
Jacobo Mintzer, Krista L Lanctôt, Roberta W Scherer, et al.
International Journal of Geriatric Psychiatry
|
June 10, 2024
Adverse effects of methylphenidate for apathy in patients with Alzheimer's disease (ADMET2 trial)
Lijuan Zeng, Jamie Perin, Alden L Gross, et al.
Pacing and Clinical Electrophysiology : PACE
|
October 15, 2010
Implantation success and infection in cardiovascular implantable electronic device procedures utilizing an antibacterial envelope
Heather L Bloom, Luis Constantin, Daniel Dan, et al.
American Journal of Human Genetics
|
January 16, 2002
Mutations in a novel CLN6-encoded transmembrane protein cause variant neuronal ceroid lipofuscinosis in man and mouse
Hanlin Gao, Rose-Mary N Boustany, Janice A Espinola, et al.
Neurology
|
July 12, 2015
Improving clinical cognitive testing: report of the AAN Behavioral Neurology Section Workgroup
Kirk R Daffner, Seth A Gale, A M Barrett, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry
|
June 23, 2020
Measuring Apathy in Alzheimer's Disease in the Apathy in Dementia Methylphenidate Trial 2 (ADMET 2): A Comparison of Instruments
Krista L Lanctôt, Roberta W Scherer, Abby Li, et al.
Page
of 38